FdaApplication
NDA 210875
Identifiers
- fda_app_no: NDA210875
Properties
| Property | Value |
|---|---|
| applicant_name | SUMITOMO PHARMA AMERICA INC |
| application_type | NDA |
| approval_date | 2020-05-21 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | 25MG | FILM;SUBLINGUAL |
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | 15MG | FILM;SUBLINGUAL |
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | 10MG | FILM;SUBLINGUAL |
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | 20MG | FILM;SUBLINGUAL |
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | 30MG | FILM;SUBLINGUAL |
5 products